Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | LSS | P48449 | 1/20 | 0.61 |
| ▸ | AKT1 | P31749 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.52 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.52 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.52 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.52 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.52 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.48 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22137841 | 0.92 | GCGR (0.59) | GCGRLMNAMAPTLSSAKT1 | |
| SCHEMBL135626 | 0.84 | MAPT (0.92) | GCGRLMNAMAPTKDM4ESMN1; SMN2 | |
| SCHEMBL10000032 | 0.84 | MAPT (0.92) | GCGRLMNAMAPTKDM4ESMN1; SMN2 | |
| SCHEMBL3558118 | 0.83 | GCGR (0.55) | GCGRLMNAMAPTLSSAKT1 | |
| SCHEMBL6782503 | 0.82 | PDGFRB (0.54) | GCGRLMNAMAPTLSSAKT1 | |
| SCHEMBL4735385 | 0.81 | CYP19A1 (0.57) | GCGRLMNAMAPTLSSKDM4E | |
| SCHEMBL14690989 | 0.81 | — | — | |
| SCHEMBL6842 | 0.81 | — | — | |
| SCHEMBL3952742 | 0.80 | CYP1A2 (0.73) | LMNARAB9ACYP1A2NOTUMKIF11 | |
| SCHEMBL28215 | 0.80 | CYP1A2 (0.73) | LMNARAB9ACYP1A2NOTUMKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099595-A1 | HYDROGEL-BASED DELIVERY SYSTEM FOR INDUCTION OF INTRATUMORAL TERTIARY LYMPHOID STRUCTURES AND AUGMENTATION OF IMMUNE CHECKPOINT BLOCKADE AND METHODS THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2025-03-27 | — | — | US | claimed |
| CN-119656163-A | Hydrogel-based delivery system and method for inducing intratumoral tertiary lymphoid structure and enhancing immune checkpoint blockade | 香港大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119409858-A | Protonated product of pyridine derivative and compound, preparation method and application thereof | 天津师范大学 | 2025-02-11 | — | — | CN | claimed |
| US-4533735-A | Process for preparing antibacterial compounds | ETHYL CORPORATION (US) | 1985-08-06 | — | — | US | claimed |
| US-4405792-A | Substituted pyridines and their preparation | ETHYL CORPORATION (US) | 1983-09-20 | — | — | US | claimed |
| US-20250099595-A1 | HYDROGEL-BASED DELIVERY SYSTEM FOR INDUCTION OF INTRATUMORAL TERTIARY LYMPHOID STRUCTURES AND AUGMENTATION OF IMMUNE CHECKPOINT BLOCKADE AND METHODS THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2025-03-27 | — | — | US | disclosed |
| CN-119656163-A | Hydrogel-based delivery system and method for inducing intratumoral tertiary lymphoid structure and enhancing immune checkpoint blockade | 香港大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-119409858-A | Protonated product of pyridine derivative and compound, preparation method and application thereof | 天津师范大学 | 2025-02-11 | — | — | CN | disclosed |
| CN-117586179-A | GPR183 antagonist and synthetic method and application thereof | 中国人民解放军海军特色医学中心 | 2024-02-23 | — | — | CN | disclosed |
| CN-117229111-A | Dehydroaromatization method for aryl cyclic hydrocarbon | 五邑大学 | 2023-12-15 | — | — | CN | disclosed |
| US-20230278996-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE S.A. (PL) | 2023-09-07 | — | — | US | disclosed |
| US-20230278996-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE S.A. (PL) | 2023-09-07 | — | — | US | disclosed |
| US-4604467-A | Certain 4-(3,4-dibromocyclohexyl)pyridines | ETHYL CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| US-4552963-A | Preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid | ETHYL CORPORATION (US) | 1985-11-12 | — | — | US | disclosed |
| US-4552964-A | 4-(1-Chlorocyclohex-3-enyl)pyridines and preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid | ETHYL CORPORATION (US) | 1985-11-12 | — | — | US | disclosed |
| US-4550167-A | Preparation of 1-alkyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinoline carboxylic acid | ETHYL CORPORATION (US) | 1985-10-29 | — | — | US | disclosed |
| US-4533735-A | Process for preparing antibacterial compounds | ETHYL CORPORATION (US) | 1985-08-06 | — | — | US | disclosed |
| US-4490535-A | 4-(3- and 4-Chlorocyclohex-3-enyl)pyridine intermediates | ETHYL CORPORATION (US) | 1984-12-25 | — | — | US | disclosed |
| US-4405792-A | Substituted pyridines and their preparation | ETHYL CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4405792-A | Substituted pyridines and their preparation | ETHYL CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099595-A1 | HYDROGEL-BASED DELIVERY SYSTEM FOR INDUCTION OF INTRATUMORAL TERTIARY LYMPHOID STRUCTURES AND AUGMENTATION OF IMMUNE CHECKPOINT BLOCKADE AND METHODS THEREOF | ICOS, CD274, LY96 | GCGR 463/4885LMNA 4237/4885MAPT 3200/4885 |
| US-20230278996-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | CHI3L1, CHI3L2, CHIA | GCGR 2274/4885LMNA 3086/4885MAPT 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.